Invivyd, Inc. Files 8-K with Financials
Ticker: IVVD · Form: 8-K · Filed: Feb 24, 2025 · CIK: 1832038
| Field | Detail |
|---|---|
| Company | Invivyd, INC. (IVVD) |
| Form Type | 8-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, regulatory-filing
TL;DR
Invivyd filed an 8-K for financials, nothing major yet.
AI Summary
Invivyd, Inc. filed an 8-K on February 24, 2025, reporting events as of February 21, 2025. The filing primarily concerns financial statements and exhibits, with no specific material events detailed in the provided text. The company, formerly known as Adagio Therapeutics, Inc., is incorporated in Delaware and based in Waltham, MA.
Why It Matters
This 8-K filing indicates that Invivyd, Inc. is providing updated financial statements and exhibits to the SEC, which is a standard regulatory requirement for public companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, not indicating any immediate material adverse events.
Key Numbers
- 001-40703 — SEC File Number (Invivyd's SEC filing identifier)
- 85-1403134 — IRS Employer Identification No. (Invivyd's tax identification number)
Key Players & Entities
- Invivyd, Inc. (company) — Registrant
- Adagio Therapeutics, Inc. (company) — Former company name
- February 21, 2025 (date) — Date of earliest event reported
- February 24, 2025 (date) — Filing date
- Waltham, MA (location) — Principal executive offices
FAQ
What specific financial statements or exhibits are being filed with this 8-K?
The provided text states that the filing includes 'Financial Statements and Exhibits' but does not specify the exact nature or content of these documents.
Are there any other material events reported in this 8-K besides financial statements and exhibits?
Based on the provided text, the filing is categorized under 'Other Events' and 'Financial Statements and Exhibits,' with no other specific material events detailed.
When was Invivyd, Inc. formerly known as Adagio Therapeutics, Inc.?
The date of the name change from Adagio Therapeutics, Inc. to Invivyd, Inc. was November 12, 2020.
What is Invivyd, Inc.'s principal executive office address?
Invivyd, Inc.'s principal executive offices are located at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.
What is the SIC code for Invivyd, Inc.?
The Standard Industrial Classification (SIC) code for Invivyd, Inc. is 2836, which corresponds to 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding Invivyd, Inc. (IVVD).